(Q31886650)

4 July 2017

Benefits of micronised Fenofibrate in type 2 diabetes mellitus subjects with good glycemic control (English)

1 reference

4 July 2017

1 reference

Tan CE

1

1 reference

4 July 2017

Chew LS

2

1 reference

4 July 2017

Tai ES

3

1 reference

4 July 2017

Chio LF

4

1 reference

4 July 2017

Lim HS

5

1 reference

4 July 2017

Loh LM

6

1 reference

4 July 2017

Shepherd J

7

1 reference

4 July 2017

1 February 2001

1 reference

4 July 2017

1 reference

4 July 2017

154

1 reference

4 July 2017

2

1 reference

4 July 2017

469-474

1 reference

Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Effect of sulfonylurea therapy on plasma lipids and high-density lipoprotein composition in non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Effect of alpha-glucosidase inhibitor in combination with sulphonylurea compounds on lipid profile in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Atherogenic lipoprotein phenotype in type 2 diabetes: reversal with micronised fenofibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Effects of ciprofibrate on LDL metabolism in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900497-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(00)00497-4

1 reference

4 July 2017

1 reference